PRESS RELEASE published on 01/29/2024 at 17:40, 7 months 21 days ago Valbiotis presents its 2024 financial communication calendar Valbiotis presents its 2024 financial communication calendar. The company specializing in dietary supplements announces publication dates for the 2023 annual report and 2024 half-year report, as well as the Annual General Meeting Financial Communication Calendar Valbiotis Dietary Supplements Metabolic Diseases Cardiovascular Diseases
PRESS RELEASE published on 01/29/2024 at 17:40, 7 months 21 days ago Valbiotis publie son calendrier financier de l’exercice 2024 Valbiotis publie son calendrier financier pour l'exercice 2024 avec les dates de publication du rapport annuel 2023, de l'assemblée générale annuelle et du rapport semestriel 2024 Calendrier Financier Valbiotis Exercice 2024 Compléments Alimentaires Innovation Scientifique
PRESS RELEASE published on 11/07/2023 at 17:40, 10 months 12 days ago Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 11/07/2023 at 17:40, 10 months 12 days ago Valbiotis annonce le succès de l’étude clinique de mode d’action sur TOTUM•63, contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE published on 11/06/2023 at 17:40, 10 months 13 days ago Valbiotis : Déclaration mensuelle du nombre d’actions et droits de vote – Octobre 2023
PRESS RELEASE published on 10/04/2023 at 17:40, 11 months 15 days ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
PRESS RELEASE published on 10/02/2023 at 17:40, 11 months 17 days ago VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
PRESS RELEASE published on 10/02/2023 at 17:40, 11 months 17 days ago VALBIOTIS SA : l’étude de Phase II/III REVERSE-IT sélectionnée pour une présentation orale au congrès 2023 de l’EASD, principale société savante européenne pour le diabète
PRESS RELEASE published on 09/28/2023 at 17:40, 11 months 21 days ago Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE published on 09/28/2023 at 17:40, 11 months 21 days ago Valbiotis publie son rapport financier pour le premier semestre 2023 et confirme sa feuille de route stratégique
Published on 09/19/2024 at 17:30, 57 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 1 hour 27 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 2 hours 42 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 15:20, 3 hours 7 minutes ago Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Published on 09/19/2024 at 15:01, 3 hours 26 minutes ago ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Published on 09/19/2024 at 17:52, 34 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 34 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 35 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 42 minutes ago AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de
Published on 09/19/2024 at 17:45, 42 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 42 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 42 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)